Movie magic: new study tests films to keep kids still during cancer treatment
NCT ID NCT05148078
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tested an interactive movie system called PROMISE to help children aged 3-11 stay still during radiation therapy for cancer, aiming to reduce the need for general anesthesia. The study enrolled 30 children and compared the rate of anesthesia use to a historical average of 70%. If it works, this approach could lower risks and improve the experience for young patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- interactive movie system (PROMISE) with video surveillance gating
- What this could lead to
- If successful, this could offer a non-drug way to keep children still during radiation, reducing the need for anesthesia and its risks.
- What could go wrong
- This is a small, single-center phase II trial with only 30 participants, so results may not apply broadly. It may not work for all children, especially those with conditions requiring anesthesia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
30 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 to 11 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Planned to undergo radiation treatment 2. Age 3-11 years 3. Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 at screening 4. Parents or guardians with the ability to understand and the willingness to sign a written informed consent. Exclusion Criteria: 1. Subjects with documented medical behavior conditions or other conditions necessitating anesthesia use 2. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that, in the opinion of the investigator, would limit compliance with study requirements. 3. Subjects whose parents opt to not include them (the subject) in the clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center Dallas
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can freezing ovarian tissue protect fertility in children facing cancer treatment?
- Tumor profiling may unlock targeted drug options for pediatric cancers
- Can a new pill tame childhood cancers that Won't quit?
- A bike ride could reveal hidden heart risks in young cancer survivors
- Can a new combo drug tame childhood leukemia that Won't quit?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?